Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.NICE recommends Abbot’s psoriasis drug
The National Institute for Health and Clinical Excellence (NICE) has recommended adalimumab as a treatment option for adults with plaque psoriasis for whom anti-tumour necrosis factor treatment is
The National Institute for Health and Clinical Excellence (NICE) has recommended adalimumab as a treatment option for adults with plaque psoriasis for whom anti-tumour necrosis factor treatment is
The potential annual sales by ANDAPharm with this product, including an earlier contract with a second pharmaceutical company, are between $7.5 million and $8 million. John Copanos, ANDAPharm’s
The product will include a heart disease pre-test risk calculator, a coronary disease reversal and prevention practice management program, a web-based, patient centric, disease reversal and life style
Kinrix (diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine], manufactured by GlaxoSmithKline, is said to be the latest combination vaccine. Clinical studies of Kinrix
Under the collaboration, the Novartis Institute for Tropical Diseases (NITD) and the TB Alliance will share information on new and ongoing tuberculosis (TB) drug discovery projects. The agreement
In addition to its injectable formulation, Jade Pharmaceutical (JPI) anticipates offering Goodnak in capsules and an easy-to-apply lotion. Based on general market information, the proposed pricing for these
Under terms of these agreements, Bayer will supply Barr with the generic products for launch prior to the expiration of the patents protecting these products and Barr will
Under a 2007 agreement between the two companies, Micromet and Nycomed develop MT203, a fully human anti-GM-CSF antibody that may be useful for the treatment of various inflammatory
The studies will be conducted by Charles River Laboratories, and follows a recently completed 28-day preclinical safety program, also performed by Charles River. AKP-020 is the product designation
The Aethlon Hemopurifier is a medical device created to provide real-time therapeutic filtration of infectious viruses and immunosuppressive proteins. According to the company, the Hemopurifier holds promise to